Thrombocytopenia as well as anti-platelet factor 4/heparin (PF4/H) antibodies are common
in cardiac surgery patients and those treated in the intensive care unit. In contrast, heparin …

Background Argatroban, lepirudin, desirudin, bivalirudin, and danaparoid are commonly
used to manage heparin-induced thrombocytopenia related complications. However, the …

To prevent thromboembolic events associated with heparin-induced thrombocytopenia
(HIT), patients usually are treated with argatroban, lepirudin, and bivalirudin. Here, we …

Heparin-induced thrombocytopenia (HIT) is a rare but potentially severe complication of
heparin therapy that is strongly associated with venous and arterial thrombosis (HIT and …

Heparin-induced thrombocytopenia (HIT) is a recognized complication of heparin and
requires urgent detection and treatment. HIT can be divided into two types, type I and type II …

水蛭素(hirudin) 为特异性凝血酶抑制剂, 根据其来源可分为天然水蛭素和重组水蛭素两类.
水蛭素具有抗凝, 抗血栓, 抗纤维化, 抗细胞凋亡, 舒血管和提高随意皮瓣成活率等多种药理作用 …

Background Little is known with regards to the prognostic factors for patients with suspected
or diagnosed Heparin-Induced Thromobocytopenia (HIT). The role of patient and therapy …

Patients receiving extracorporeal membrane oxygenation (ECMO) are at risk of circuit
thrombosis due to constant contact between blood and the extracorporeal components …

目的评价直接凝血酶抑制剂阿加曲班在肾脏替代治疗中应用的作用效果.
方法以“阿加曲班”,“透析”,“肾功能”,“肾功能衰竭”,“肾脏替代治疗” 为关键词, 在Cochrane 图书馆 …

目的探讨合理的比伐卢定临床序贯给药方案. 方法筛选健康受试者12 名, 给予比伐卢定0.75
mg/kg 静脉推注后, 1.75 mg· kg-1· h-1 的速度匀速静滴4 h, 不同时间点采集血样, 测定血药浓度 …